key: cord-1011552-wl584d6b
authors: Moris, Dimitrios; Tsilimigras, Diamantis I; Schizas, Dimitrios
title: Cancer and COVID-19
date: 2020-10-08
journal: Lancet
DOI: 10.1016/s0140-6736(20)32069-9
sha: ee16466581a38914eee4225295b4cecaadb73487
doc_id: 1011552
cord_uid: wl584d6b

nan

during the pandemic, the prioritisation in the delivery of cancer therapies is strongly influenced by the magnitude of potential treatment benefits, therapeutic intent, and the access to care. 5 All in all, these changes can definitely affect the outcomes of patients with cancer. In this new landscape, when the cancer community is revising the optimal standards of cancer care, research should focus on identifying the factors that contribute to avoidable mortality and facilitate the implementation of strategies to benefit patients.

We declare no competing interests. therapeutic plan caused by COVID-19, including access to care and delays in management? Information on deaths caused by changes to a patient's care plan is of paramount clinical importance, since data on the incidence of avoidable mortality caused by the effect of the pandemic on health-care resources are scarce. During the pandemic, the management of patients with cancer has been affected at multiple stages, including the triage decisions, surgery, and neoadjuvant therapy as a bridge to reduce admissions and preserve health-care resources. 2 Also, when possible, oncologists are modifying or substituting oral for intravenous chemotherapy with oral agents to minimise admissions to hospital.

In the same vein, omissions, delays, or fragmentation of care can have clinically important adverse influence on quality of life or survival. 2 Unfortunately, the effect on the survival outcomes is not well described in the literature, and data from international cohorts and consortia can be useful.

Finally, the authors did not provide any data on the socioeconomic and insurance status of the patients included in their cohort. It would be interesting to know how many patients with cancer lost their insurance, dependent care, or employment, and how these changes affected their access to care and a treatment plan.

COVID-19 has caused unprecedented societal turmoil, triggering a rapid transformation of health-care systems on a global scale. Emerging data show that the COVID-19 pandemic has the potential to amplify pre-existing disparities, especially for patients with cancer. 3 

Detection of SARS-CoV-2 in human breastmilk

COVID-19, breastfeeding, infant feeding, breast milk -literature repository

Feb-Aug_2020)_(updated_21_August)_FINAL.pdf

Neonatal late onset infection with severe acute respiratory syndrome coronavirus 2

Virolactia in an asymptomatic mother with COVID-19

Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19)

Breast milk transmission of viral disease

We read, with great interest, about the outcomes in a cohort of patients with cancer and COVID-19 by Nicole Kuderer and colleagues. 1 The authors showed that among patients with cancer and COVID-19, 30-day all-cause mortality was high and associated with general and cancerspecific risk factors, with a mortality of 13·3%.More data on the cause of mortality in the CCC19 cohort would have been useful. More specifically, how many patients died because of COVID-19related issues (eg, acute respiratory distress syndrome or organ failure), and how many died because of background disease progression and relevant complications? Finally, how many of these deaths should be attributed to changes in the Nicole Kuderer and colleagues 1 identified several independent prognostic factors to be conferring an increased risk of 30-day allcause mortality: increased age, male sex, being a former smoker, multiple medical comorbidities, high Eastern Cooperative Oncology Group performance status score (≥2), and an active cancer. However, haematological malignancies, instead of increasing 30-day all-cause mortality, were associated with severe clinical outcomes, intensive care unit